Chinese chipmaker Iluvatar CoreX to raise $850 million in Hong Kong after share surge

On July 8, 2026, Shanghai Iluvatar CoreX Semiconductor Co. announced plans to raise about $850 million through a follow-on share offering on the Hong Kong Stock Exchange. The move comes after a significant rally in the company's stock since its IPO in January 2026 — the shares have "soared," as Bloomberg put it.

Why a share sale now?

Iluvatar CoreX listed in Hong Kong in January 2026, and its stock has climbed sharply since then. For a public company riding a rally, a secondary offering is a standard and logical move: a high share price lets it raise more money while selling a smaller stake. This is not an urgent need for funding but a smart use of a market window.

Bloomberg does not disclose the exact percentage gain since the IPO, but the decision to sell $850 million in shares speaks volumes about investor demand. Buyers get a way into a growing AI story through a liquid, exchange-traded instrument — without the restrictions of private venture rounds.

With China's AI industry on the rise, backed by government programs and corporate demand, AI chipmakers have become one of the hottest sectors on the Hong Kong market. Large primary and secondary offerings by AI companies have followed one after another there since 2025.

Who is Iluvatar CoreX, and where will the money go

Shanghai Iluvatar CoreX Semiconductor Co. is one of China's leading AI accelerator developers. The company designs GPU-like processors for machine learning workloads: training and inference of large language models, computer vision, and scientific and engineering computing.

• Amount: about $850 million
• Format: follow-on share offering (secondary placement)
• Venue: Hong Kong Stock Exchange
• Company IPO: January 2026
• Profile: developer of AI accelerators for ML and HPC

U.S. export restrictions on NVIDIA's advanced chips — the H100, H200, and B200 series — have created sustained demand in China for domestic alternatives. Iluvatar CoreX is among the main beneficiaries. The competitive landscape, however, is getting more crowded: Huawei Ascend and other local players are also building up their AI chip capabilities. The new funds will help the company hold on to its technological lead. Bloomberg does not disclose how specifically the money will be spent.

Why Hong Kong and not the mainland exchanges

The Hong Kong Stock Exchange remains the main gateway for Chinese tech companies seeking international capital. A listing there opens access to global institutional investors operating under common law, while direct foreign access to the Shanghai and Shenzhen exchanges is significantly restricted.

In 2025–2026, Hong Kong has deliberately positioned itself as a regional AI finance hub: the SFC regulator eased a number of requirements for tech issuers, and several major AI companies have already carried out primary and secondary offerings there. For Iluvatar CoreX, which already completed its Hong Kong IPO in January 2026, it is the natural venue for its first major follow-on offering — the investor base is already in place, and the listing rules are familiar.

What it means

The $850 million raise confirms that global investors see China's AI chip market as long-term structural growth rather than short-term hype. Iluvatar CoreX is skillfully using two tailwinds — a high share price and a shortage of Western accelerators — to build a capital base for the next round of the competitive race. How effectively the company turns this money into technological leadership will become clear over the coming operating year.